Commercialization: Page 67

PharmaVoice Team/PharmaVoice

Tools of the Trade

FDA Basics for Industry is a Web-based resource provided by the Food and Drug Administration with the goal of helping companies save time and resources in their interactions with the agency. The website, fda.gov/FDABasicsforIndustry, provides information about the regulatory process, including in...
By PharmaVoice Team • March 3, 2011
PharmaVoice Team/PharmaVoice

PharmaTrax

Pharmaceutical companies will see an opportunity to increase their visibility with consumers, influence health outcomes, and reduce healthcare costs while increasing revenue using digital strategies and technology, according to Top Health Industry Issues of 2011, a report published by the Pricewa...
By PharmaVoice Team • March 3, 2011
PharmaVoice Team/PharmaVoice

Outlet

According to a new study, media coverage of HIV/AIDS fell more than 70% in developed countries over the last two decades. The Trends in Sustainability Project — a joint project of the University of Leeds, Queen’s University Belfast, the Berlin-based Institute for Futures Studies and Technology As...
By PharmaVoice Team • March 3, 2011
PharmaVoice Team/PharmaVoice

UpFront

Patent Cliff By 2016 medicines that generate sales of $133 billion for their manufacturers in the U.S. alone will be exposed to generics, including drugs worth $33.2 billion in 2011 that will lose patent protection in 2012, more than double this year’s figure, according to EvaluatePharma Ltd. P...
By PharmaVoice Team • March 3, 2011
PharmaVoice Team/PharmaVoice

Reader Feedback

Who Inspires You? PharmaVOICE Wants to Know! Each year the PharmaVOICE 100 is determined by the collective participation of you, our readers. This is your opportunity to recognize the people who inspire and motivate you and others; who are having the greatest influence on corporate leadership, re...
By PharmaVoice Team • March 3, 2011
PharmaVoice Team/PharmaVoice

Letter from the Editor

Cheers! Time flies when one is having fun. And the last 10 years have been extremely fun and extremely rewarding. It’s been great getting to know so many of you throughout the life-sciences industry. Back in 2001, the term life-sciences was not common, in fact many questioned us as to what it mea...
By PharmaVoice Team • March 3, 2011
PharmaVoice Team/PharmaVoice

The Push and Pull of Patient Recruitment

There are two sides to patient recruitment: the “push" (advertising) and the “pull" (referral management to randomization). While many companies focus a lot of effort on the push side of recruitment, the importance of the pull can often be overlooked. Yet this is where the rubber meets the road. ...
By Liz Moench • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

Achieving More Precise Patient Recruitment

While pharmaceutical market researchers have benefited from comprehensive, secondary data sources and sophisticated analytics for years, the R&D functions and clinical research organizations (CROs) were on the outside looking in when it came to access to this information and analytical approa...
By Michel Denarié and Robert Kraft • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

Global Patient Recruitment: Preventing Delays Through Knowledge Application

Enrollment of clinical trial subjects in far-ranging global destinations has become desirable for many drug developers. Generally, these regions offer a large pool of relatively treatment-naïve patients, GCP-standard medical facilities, capable health care professionals and a substantially lower ...
By Sandra Chase • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

Last Word

PV: What should the goals of a corporate social media program be? Adler: There are many opportunities for companies to engage in social media; generally these fall into three categories. Certainly, chief among the reasons to embark upon a proactive social media program is to enhance awareness amo...
By PharmaVoice Team • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

Talent Pool

Pharmaceutical POOL Robert DAVIS Dr. Ludwig HANTSON Baxter International Forms Medical Products Business Baxter International has appointed Robert Davis corporate VP and president of its newly created medical products business, which combines the company’s renal and medication delivery businesses...
By PharmaVoice Team • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

Social Media

Pharma is Using Social Media, With Reservations Trend Watch: More than 65% of life-sciences company professionals say their company uses or plans to use social networks at a company level, according to a report by Deloitte. Social Media Leveraging Online Social Networks Innovative companies are ...
By PharmaVoice Team • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

PharmaTrax

Trend: With its traditional business model breaking down amid scant financing and lengthy R&D processes, the biotech sector needs to reinvent itself by adopting a more collaborative approach to capitalize on emerging healthcare opportunities. According to the PricewaterhouseCoopers (PwC) rep...
By PharmaVoice Team • Jan. 26, 2011
PharmaVoice Team/PharmaVoice

Using Social Media to Listen Before You Leap

e-Patients: Much More Than Targets Technology has given rise to a new kind of patient—one who is empowered, educated, and hungry for information that digital media can provide. These e-Patients have captured the imagination of healthcare marketers, who are poised to spend $1.12 billion in 2011 (p...
By Chris Kelly • Dec. 29, 2010
PharmaVoice Team/PharmaVoice

Quick Response Codes (QR) Codes - The Next Frontier for Pharma

Those little ink blot-like codes are cropping up everywhere — in consumer newspapers and magazines, out-of-home advertising, brochures, in stores, and elsewhere. When you snap a picture of them with your mobile device they take your handheld to brave new worlds of content. Being QR code savvy mig...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Engaging the Empowered E-Patient

Engaging the Empowered E-Patient The growing consumer use and exchange of online health information is changing the balance of power in the patient-physician relationship by enabling the consumer to take a more active and informed role in making decisions about their healthcare. n the 2010 editi...
By Carolyn Gretton • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

SFE With a New Business Model

There’s been much discussion over the past few years about the industry moving to a more consumer-centric sales model, and the time has come for a little less conversation and a little more action. The myriad challenges facing the industry and the increased adoption of technology by physicians ha...
By Robin Robinson • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Achieving Global Launch Excellence

The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incent...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Millennials: Problems or Prodigies?

Our experts say, however, this is a generation worth catering to, because if they are happy, they will most certainly succeed. Getting all four generations to work together effectively is challenging because the generations have difficulty relating to one another as they interact in the workplace...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Talent Pool

Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President Achillion Pharmaceuticals, which is focused on the discovery and development of small-molecule drugs to combat challenging infectious diseases, has promoted Chief Scientific Officer Milind Deshpande, Ph....
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Social Media

CMP.LY to Address FDA/FTC Requirements Proponents of using the Internet for dispersing information and marketing efforts in the life-sciences field soon will have some alternative solutions that will allow the industry to continue its cautious move toward social media. One of those solutions was ...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

PharmaTrax

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: A Consistent Life-Cycle Management Strategy Can Counter Market Threats Innovation Remains Key to Drug Approval Strategy Sidebars: First-Cycle Approval Rates for Original NDAs (FY2003-FY2009) LCM Strategy Targeting Can M...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

The Reps of Tomorrow

Given the environmental and sales target changes, the sales model must change to a concierge model, our experts say. This requires a very different approach and even a different type of salesperson. “Pharma companies can learn much from management consulting and service-selling skills," says Dave...
By Robin Robinson • Nov. 12, 2010
PharmaVoice Team/PharmaVoice

Digital Sales Tools Open Physician Doors

Digital media touch all facets of the relationship between pharmaceutical companies and prescribers. The reliance on building and sustaining the customer relationship through face-to-face interactions is changing dramatically. The increase in multichannel communications with customers and in part...
By Robin Robinson • Nov. 12, 2010
PharmaVoice Team/PharmaVoice

Unbranded Strategies Move From the Back Seat to the Driver's Position

In the future, the use and the value of unbranded promotion and messaging will continue to grow. Leigh Householder GSW Worldwide “The second biggest metric in pharma —behind sales — is sustained behavioral change, which means inspiring people to adopt healthier behaviors and adhere to treatment....
By Robin Robinson • Nov. 12, 2010